ArticleBMC oral health2026
The therapeutic potential of local injection of leptin for periodontitis in rats: an investigation based on the OPG/RANKL mechanism.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivePeriodontitis is a prevalent oral disease characterized by the destruction of tooth-supporting tissues. It exhibits a close association with leptin, a pleiotropic adipokine; however, the specific role and underlying mechanism of leptin in periodontitis remain largely elusive. In this study, a rat model of experimental periodontitis was established. Local injections of leptin and leptin antagonist were administered into the periodontal tissues of rats, respectively. By examining the histopathological and morphological changes of the periodontal tissues, as well as detecting the expression levels of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) in these tissues, we aimed to investigate the effects of local leptin levels on the progression of periodontitis.
methodsA ligature-induced periodontitis model was established in Wistar rats. The rats were randomly divided into three groups: periodontitis + leptin (leptin group), periodontitis + saline (saline group), and periodontitis + leptin antagonist (antagonist group). Each group received local injections of leptin (0.4 µg per rat per time), saline (10 µL per rat per time), or leptin antagonist (0.1 µg per rat per time) in the periodontal tissue once every three days for a total of four weeks. Seventy-two hours after the last injection, the rats were sacrificed. Hematoxylin and eosin (HE) staining was used to observe histopathological changes in the periodontal tissues; micro-CT was used to examine alveolar bone parameters; and immunohistochemistry (IHC) and RT-PCR were performed to detect the expression of OPG and RANKL in the periodontal tissues of the rats.
resultsAfter 8 weeks of ligature, periodontitis was successfully induced. The rats in the leptin group presented significantly alleviated periodontitis symptoms. The extent of alveolar bone resorption in the leptin group was significantly lower than that in the saline and antagonist groups (P < 0.05). OPG expression protein in the periodontal tissue of the leptin group was significantly greater than that in the saline and antagonist groups (P < 0.05), whereas RANKL expression was significantly lower in the leptin group than in the saline and antagonist groups (P < 0.05).
conclusionLocal periodontal injection of leptin reduces the level of periodontal inflammation in rats with experimental periodontitis, mitigates alveolar bone resorption, increases OPG expression, and decreases RANKL expression. This study suggests that local periodontal injection of leptin may exert a protective effect against periodontal tissue destruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.